Profile data is unavailable for this security.
About the company
Hangzhou Alltest Biotech Co Ltd is a China-based company principally engaged in the research, development, production, and sales of in vitro diagnostic reagents. The Company’s main products are rapid diagnostic reagents, including Women's Health Rapid Test, Infectious Disease Rapid Test, Drug of Abuse Rapid Test, Tumor Markers Rapid Test and Cardiac Markers Rapid Test. The Company also engages in the production and sales of veterinary test products. The Company’s main brands include Alltest, Juscheck and Beright. The Company mainly operates its businesses in the domestic market and overseas markets.
- Revenue in CNY (TTM)881.63m
- Net income in CNY294.76m
- Incorporated2009
- Employees969.00
- LocationHangzhou Alltest Biotech Co LtdFactory Building No. 3, 4, & 5, No. 550Yinhai Street, Baiyang NeighborhoodHangzhou Economic and Technological DeveHANGZHOU 310018ChinaCHN
- Phone+86 57 156207860
- Fax+86 57 156267856
- Websitehttps://www.alltests.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xinjiang Bai Hua Cun Pharma Tech Co Ltd | 393.73m | 50.20m | 3.59bn | 731.00 | 71.38 | 4.52 | -- | 9.11 | 0.1307 | 0.1307 | 1.02 | 2.06 | 0.3503 | 1.94 | 1.88 | 538,619.70 | 4.47 | -4.60 | 6.16 | -6.38 | 51.82 | 24.75 | 12.75 | -16.33 | 1.81 | -- | 0.00 | -- | 4.46 | 8.04 | 219.75 | 3.82 | -0.975 | -- |
| Qingdao Vland Biotech INC | 1.39bn | 83.57m | 4.02bn | 1.57k | 48.33 | 2.27 | -- | 2.89 | 0.329 | 0.329 | 5.50 | 7.01 | 0.4585 | 3.89 | 3.65 | -- | 3.76 | 4.84 | 6.11 | 6.94 | 44.19 | 45.52 | 8.20 | 9.54 | 0.877 | -- | 0.2648 | 32.35 | 10.16 | 9.30 | -22.39 | -4.23 | -2.71 | -6.89 |
| Hinova Pharmaceuticals Inc | 23.61m | -144.57m | 4.56bn | 173.00 | -- | 4.15 | -- | 193.34 | -1.46 | -1.46 | 0.2384 | 11.12 | 0.0171 | 2.37 | 5.59 | 136,467.70 | -10.45 | -26.09 | -11.68 | -29.74 | 95.50 | -- | -612.36 | -78,863.60 | 6.90 | -- | 0.0883 | -- | -- | -38.67 | 32.18 | -- | 139.77 | -- |
| Shanghai Aladdin Biochemical Tech Co Ltd | 599.98m | 83.95m | 5.33bn | 652.00 | 64.42 | 4.99 | -- | 8.88 | 0.2485 | 0.2485 | 1.78 | 3.21 | 0.2785 | 0.4218 | 4.55 | 920,216.30 | 5.04 | 7.81 | 6.90 | 8.60 | 62.21 | 60.61 | 18.09 | 24.95 | 1.53 | 9.15 | 0.3541 | 48.33 | 32.44 | 20.55 | 15.07 | 9.17 | 41.61 | -- |
| Hangzhou Alltest Biotech Co Ltd | 881.63m | 294.76m | 5.48bn | 969.00 | 18.55 | 1.40 | -- | 6.21 | 3.72 | 3.72 | 11.12 | 49.21 | 0.2098 | 2.38 | 6.39 | 909,839.10 | 7.02 | 19.18 | 7.57 | 21.66 | 55.00 | 57.79 | 33.47 | 38.82 | 8.34 | -- | 0.0093 | 35.14 | 14.83 | 29.13 | 67.50 | 30.99 | 71.01 | -- |
| Bide Pharmatech Co Ltd | 1.27bn | 153.31m | 5.49bn | 738.00 | 34.35 | 2.74 | -- | 4.32 | 1.76 | 1.76 | 14.49 | 22.03 | 0.5167 | 0.8804 | 5.25 | 1,720,520.00 | 6.24 | 7.02 | 7.52 | 8.29 | 43.30 | 42.16 | 12.07 | 13.13 | 2.78 | -- | 0.1055 | 48.73 | 0.9298 | 34.69 | 7.17 | -- | 80.65 | -- |
| Shouyao Holdings Co Ltd | 2.14m | -206.73m | 6.04bn | 178.00 | -- | 9.23 | -- | 2,818.82 | -1.39 | -1.39 | 0.0144 | 4.40 | 0.0025 | 0.0366 | 0.2625 | 12,033.88 | -23.67 | -32.53 | -27.20 | -36.25 | 95.74 | 99.43 | -9,651.03 | -3,370.01 | 6.42 | -- | 0.0044 | -- | -24.61 | -19.34 | -14.21 | -- | 49.71 | -- |
| Jiangsu Yahong Meditech Co Ltd | 279.02m | -362.17m | 6.93bn | 391.00 | -- | 3.91 | -- | 24.83 | -0.642 | -0.642 | 0.4933 | 3.10 | 0.125 | 11.16 | 4.19 | 713,603.90 | -16.84 | -14.30 | -19.15 | -15.01 | 72.22 | 73.78 | -134.65 | -703.80 | 4.96 | -- | 0.1545 | -- | 1,365.55 | -- | 4.09 | -- | 50.48 | -- |
| GemPharmatech Co Ltd | 752.70m | 121.51m | 7.22bn | 1.58k | 58.57 | 3.28 | -- | 9.59 | 0.3007 | 0.3007 | 1.86 | 5.37 | 0.2807 | 4.51 | 1.88 | 476,993.40 | 4.53 | 7.69 | 5.42 | 8.96 | 61.84 | 68.17 | 16.14 | 25.58 | 3.17 | -- | 0.1295 | 21.94 | 10.39 | 28.94 | -30.89 | 25.88 | 20.02 | -- |
| Beijing Sun-Novo Pharma Research Co Ltd | 1.02bn | 133.01m | 7.73bn | 1.36k | 56.81 | 6.65 | -- | 7.59 | 1.21 | 1.21 | 9.23 | 10.38 | 0.4745 | 35.48 | 1.28 | 653,956.40 | 6.04 | 11.39 | 10.49 | 18.82 | 48.60 | 53.31 | 12.72 | 19.66 | 1.78 | 9.97 | 0.3355 | 11.29 | 15.70 | 35.80 | -3.98 | 30.21 | 3.50 | -- |
Data as of Feb 11 2026. Currency figures normalised to Hangzhou Alltest Biotech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
11.39%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 787.52k | 2.10% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 667.70k | 1.78% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 516.80k | 1.38% |
| Cinda Fund Management Co. Ltd.as of 30 Jun 2025 | 447.14k | 1.19% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 2025 | 385.16k | 1.03% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 334.92k | 0.89% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 307.12k | 0.82% |
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2025 | 300.00k | 0.80% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2025 | 298.05k | 0.80% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 219.74k | 0.59% |
More ▼
Data from 30 Jun 2025 - 30 Jun 2025Source: FactSet Research Systems Inc.
